HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Health (OTC Drugs)

Set Alert for Health (OTC Drugs)

Regulation/Legislation Explore this Topic

Set Alert for Regulation and Legislation {Health}

Latest From Regulation, Legislation & Health

Sore Throat Drugs Heading Behind The Counter In France Over Safety Fears

France's drugs agency wants to restrict sales of OTC sore throat treatments marketed by Sanofi and others to behind the pharmacy counter due to fears of potential adverse events.
France Drug Safety

Health And Wellness Trademark Review 26 November, 2019

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Trademarks OTC Drugs

Australia Suspends 23 Ranitdine Products Contaminated with NDMA

A six-month suspension from sale has been handed to 23 ranitidine drugs sold in Australia. The country's regulator has suggested all 23 are facing a permanent ban over patient safety fears.

Drug Safety Enforcement

Sunscreen Industry Faces Major Challenge In GRASE Push That OTC Monograph Reform Would Solve

Industry advocates working to support GRASE determinations for eight UV filters are faced with a dilemma. They would like to share nonpublic studies with the FDA on a confidential basis – at least to get initial temperature readings from the agency as to the studies’ usefulness in addressing data gaps – but under the current OTC monograph framework, no such pathway exists.

United States FDA

FDA Plans To Publish 'Novel' OTC Switch NPRM In May 2020

Agency list in HHS Unified Agenda also states intent to publish before end of 2019 an NPRM to add the common cold indication to certain OTC monograph antihistamine ingredients. Nonbinding timelines also included for NPRM on clarifying regarding when studies to evaluate drug uses of products marketed as foods, supplements or cosmetics are subject to IND reviews.

FDA Prescription To Otc Switch

OTC Monograph Reform May Have To Launch Without User Fees, Senate Sponsor Says

"We believe that we're going to get this done," but "it's possible that ... language authorizing the collection of user fees is not included in this year's appropriation legislation," says Sen. Bob Casey during HELP Committee's confirmation hearing for FDA commissioner nominee Stephen Hahn.

OTC Drugs Legislation
See All

Business Explore this Topic

Set Alert for Business {Health}

Latest From Deals & Health

Perrigo Returns To 'Model' For Success, Expects Surprises From 2020 Launches

Perrigo "walked away a little bit" from "a model that worked beautifully," says CEO Murray Kessler at investor conference, "In essence, all we've done over the last year is to put back in place the model that worked so well."

OTC Drugs Launches

Stada’s Acquisition Spree Continues With Deal For Ukrainian Probiotics Player

Germany's Stada will gain a range of probiotics and other OTC brands through the acquisition of Ukraine's Biopharma. The deal is Stada's third in the space of just one month. 
Ukraine Deals

Sanofi Strikes Deal To Develop Respiratory Health App

Sanofi Consumer Healthcare is working with digital health firm ResApp to develop a mobile application which consumers can use to diagnose and manage respiratory illnesses. Such a tool has the potential to support novel Rx-to-OTC switch applications in future. 
Digital Health Deals
See All

Latest From Business Strategies & Health

Perrigo Returns To 'Model' For Success, Expects Surprises From 2020 Launches

Perrigo "walked away a little bit" from "a model that worked beautifully," says CEO Murray Kessler at investor conference, "In essence, all we've done over the last year is to put back in place the model that worked so well."

OTC Drugs Launches

Stada’s Acquisition Spree Continues With Deal For Ukrainian Probiotics Player

Germany's Stada will gain a range of probiotics and other OTC brands through the acquisition of Ukraine's Biopharma. The deal is Stada's third in the space of just one month. 
Ukraine Deals

Health And Wellness Trademark Review 26 November, 2019

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Trademarks OTC Drugs
See All

Latest From Sales & Earnings & Health

Perrigo's Combo For Growth: Bolt-on Acquisitions And New Products

CEO Murray Kessler says Perrigo's history shows "when it looks like we were winning, there was a certain level of bolt-on" acquisitions in addition to new products. The combination drove Perrigo in Q3 with reported worldwide consumer product net sales up 3.3% to $961m.
OTC Drugs Sales & Earnings

Bausch's Lumify Eye Drops Sales Jump To Double Competitors' Market Share

Lumify redness relief eye drops nearly doubled in sales between Bausch's second and third quarters and drove 7% organic growth of its global consumer business compared to the year-ago period. The brand has double the market share of its two closest competitors, and the firm plans clinical studies for product extensions to the brand in 2020.

OTC Drugs Dietary Supplements

Colgate Expects ‘Premiumization’ Of Oral Care To Boost North America Sales

Colgate says ‘premiumization’ of its oral care products in North America should drive improved product mix and pricing; higher-end offerings will include a recyclable Tom’s of Maine toothpaste tube and a Colgate Optic White offering. North American Q3 sales grew 1.2% to $869m.

OTC Drugs Sales & Earnings
See All

Latest From Legal Issues & Health

Perrigo Faces $370m Tax Payment From Second IRS Audit Linked To Elan Deal

Even though consumer health products and Rx generics manufacturer reported $92.2m net Q3 income after losing $67.5m a year ago, investors apparently reacted more strongly to its latest tax dispute. Its share price closed down 6.7% at $50.51 on trading at twice the stock's average volume.
OTC Drugs Tax

Amarin's Asking ITC To Do FDA's Job, Federal Attorneys Tell Supreme Court

In petition to Supreme Court, Amarin does not assert it makes any fair trade claim "that could be proved without establishing" an FDCA violation, nor does it dispute that its "claims are ultimately premised on allegations that the FDCA was violated," say DoJ solicitor general and ITC counsel.

Legal Issues Dietary Supplements

French Industry Loses Appeal Against Standardized OTC Packaging And Curb On Branding

France's highest court rules that recommendations by the national drug regulator in favor of standardized packaging for OTC drugs - including reducing prominence of brand names - and curbing the practice of umbrella branding will continue to stand after rejecting an appeal by local industry association Afipa.
Legal Issues France
See All

Marketing Explore this Topic

Set Alert for Marketing {Health}

Latest From Launches & Health

Perrigo Returns To 'Model' For Success, Expects Surprises From 2020 Launches

Perrigo "walked away a little bit" from "a model that worked beautifully," says CEO Murray Kessler at investor conference, "In essence, all we've done over the last year is to put back in place the model that worked so well."

OTC Drugs Launches

GSK Launches OTC Fluticasone In Japan Following Switch

GSK has launched Flunase in Japan following the switch of fluticasone propionate. JSMI’s Toshi Tominaga gives his assessment of the product’s prospects as an OTC drug.

Japan Prescription To Otc Switch

Switzerland’s Ricola Breathes Life Into UK Medicated Confectionery Market

Swiss confectioner Ricola wants to capitalize on a gap in the UK medicated confectionery market with its new Soothe & Clear line. 

Health OTC Drugs
See All

Latest From Ad Campaigns & Health

Don’t Miss Your Chance To Win A Prestigious OTC Marketing Award

The 25th Annual OTC Marketing Awards entry deadline is fast approaching. Don’t miss this opportunity to spotlight your recent smash launch or gain the recognition your latest campaign deserves.

Ad Campaigns Launches

Spain's Kern Pharma Combats Dry Mouth With Salifresh Launch

Spanish consumers suffering from dry mouth have a new option to turn to with the launch of Kern Pharma's Salifresh.
Spain Launches

Winners In CHPA’s First OTC Marketing Awards Include Perrigo, J&J, GSK

CHPA awarded five grand prize winners from more than 40 consumer health companies entered in its first US OTC Marketing Awards. Perrigo won for “Best OTC Corporate Social Responsibility Campaign” and a J&J Tylenol campaign honoring caregivers was named “Best OTC Digital Campaign.”
OTC Drugs Dietary Supplements
See All

Latest From Ad Complaints & Health

ASA Rap Leaves 'Alcohol Flush' Patch Manufacturer Red-Faced

Redee Solutions feels the heat from the UK advertising authority due to "irresponsible" and misleading marketing for its 'alcohol flush' trans-dermal patch.
Health OTC Drugs

Boiron Warned Over Use Of Social Media Influencer In French Ad

Using a social media influencer to promote its pro-homeopathy campaign in France without clearly indicating the post was a paid ad has landed Boiron in hot water with local regulators. 
Ad Complaints France

Bayer's Aleve 'Proven Better' Than Tylenol Claims Fail In J&J Challenge At NAD

Bayer appeals to National Advertising Review Board over NAD’s finding the firm didn't support claims its Aleve OTC provides superior pain-relief to J&J’s Tylenol. It says NAD misunderstands scientific data and it will argue pain studies it submitted were methodologically sound and pain-relief statements were not overly broad.
OTC Drugs Ad Complaints
See All
UsernamePublicRestriction

Register